J. Scott Wolchko - Jan 11, 2022 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Signature
/s/ Cindy Tahl, Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Jan 11, 2022
Transactions value $
-$709,027
Form type
4
Date filed
1/13/2022, 03:09 PM
Previous filing
Jan 12, 2022
Next filing
Feb 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Sale -$487K -10K -2.25% $48.50* 436K Jan 11, 2022 Direct F1, F2
transaction FATE Common Stock Sale -$222K -4.52K -1.04% $49.07* 432K Jan 11, 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 16,500 shares of Common Stock underlying RSUs granted to the reporting person on January 8, 2020 and 10,807 shares of Common Stock underlying RSUs granted to the reporting person on January 20, 2021. These sales were made pursuant to an irrevocable election by the reporting person to satisfy tax withholding obligations through "sell to cover" transactions and do not represent discretionary trades by the reporting person.
F2 Represents the weighted average sale price of the shares sold ranging from $47.70 to $48.69 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 3.
F3 Represents the weighted average sale price of the shares sold ranging from $48.70 to $49.40 per share.